Dean Edney

3 years ago By Yvie
  • Share on

  • Linkedin

Session – CMC Complexities & Challenges in Drug Development
Dean Edney is an accomplished scientific leader with over 25 years of experience in small molecule pharmaceutical process and product development. He joined Sai Life Sciences as the Global Head of Process R&D in January 2020 with a mandate to enhance the organization’s process research & development capability, across the UK and India, allowing its customers to accelerate their research and development programs through the rapid application of high quality science to all areas of API process research, development and manufacturing. Throughout his previous career at GlaxoSmithKline Dean demonstrated a strong track record of cross-functional leadership to deliver projects and develop capability across all phases of API process research & development, from early non-clinical supply and route scouting through to validation of commercial control strategies. He also has experience of developing both inhaled and oral solid dose pharmaceutical products including physicochemical developability criteria; the importance and control of physical properties and the regulatory requirements at each phase of development.
Dean received his BSc in Chemistry and Ph.D. in Synthetic Organic Chemistry from the University of Nottingham, UK.

More news